BioNTech (Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "BioNTech" in Croatian language version.

refsWebsite

Global rank Croatian rank

8reuters.com

49^th place

93^rd place

4web.archive.org

1^st place

4fda.gov

447^th place

2,517^th place

3bbc.com

20^th place

34^th place

3biontech.de

low place

2politico.eu

1,347^th place

4,818^th place

2france24.com

481^st place

1,413^th place

2cnbc.com

220^th place

623^rd place

2europa.eu

68^th place

35^th place

1sec.report

low place

1canada.ca

1,712^th place

low place

1swissmedic.ch

low place

1biontech-imfs.de

low place

1genomeweb.com

low place

1forbes.hu

low place

1nih.gov

4^th place

13^th place

1harvard.edu

18^th place

130^th place

1doi.org

2^nd place

12^th place

1worldcat.org

5^th place

8^th place

1fiercebiotech.com

low place

1nasdaq.com

2,740^th place

low place

1bbc.co.uk

8^th place

19^th place

1statnews.com

8,771^st place

low place

1globalnews.ca

985^th place

low place

1publishing.service.gov.uk

1,877^th place

low place

1gov.uk

432^nd place

3,805^th place

1nytimes.com

7^th place

28^th place

1gov.hu

7,700^th place

3,484^th place

bbc.co.uk

Coronavirus: EU buys 300m doses of BioNTech-Pfizer vaccine. BBC News. United Kingdom. 11. studenoga 2020. Pristupljeno 12. studenoga 2020.

bbc.com

Covid vaccine: First 'milestone' vaccine offers 90% protection. BBC News (engleski). 9. studenoga 2020. Pristupljeno 22. prosinca 2020.
Gallagher, James. 20. srpnja 2020. Coronavirus vaccine: UK government signs deals for 90 million doses. BBC News. Pristupljeno 2. kolovoza 2020.
Roberts, Michelle. 2. prosinca 2020. Covid Pfizer vaccine approved for use next week in UK. BBC (engleski). Pristupljeno 2. prosinca 2020.

biontech-imfs.de

Eufets Becomes BioNTech Innovative Manufacturing Services (engleski). BioNTech IMFS. 18. rujna 2017. Pristupljeno 11. studenoga 2020.

biontech.de

investors.biontech.de

SEC Filing | BioNTech. investors.biontech.de. Inačica izvorne stranice arhivirana 16. siječnja 2021. Pristupljeno 28. prosinca 2020.
BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs. BioNTech. 4. rujna 2019. Inačica izvorne stranice arhivirana 29. lipnja 2023. Pristupljeno 27. prosinca 2020.

biontech.de

Aiming to address the global coronavirus pandemic: Project Lightspeed. BioNTech. 2020. Pristupljeno 13. prosinca 2020.

canada.ca

Pfizer-BioNTech COVID-19 vaccine: What you should know (engleski). Pristupljeno 22. prosinca 2020.

cnbc.com

Ryan Browne. 11. studenoga 2020. What you need to know about BioNTech — the European company behind Pfizer's Covid-19 vaccine. CNBC. Pristupljeno 7. prosinca 2020.
Lovelace Jr., Berkeley. 27. srpnja 2020. Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday. CNBC. Pristupljeno 2. kolovoza 2020.

doi.org

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen. 16. lipnja 2016. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature (engleski). str. 396–401. Bibcode:2016Natur.534..396K. doi:10.1038/nature18300. ISSN 1476-4687. PMID 27281205. Pristupljeno 11. studenoga 2020.

europa.eu

ec.europa.eu

European Investment Bank provides funding of €50 million to BioNTech as part of the Investment Plan for Europe (engleski). European Commission. 17. prosinca 2019. Pristupljeno 21. studenoga 2020.
Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing (engleski). European Commission. 11. lipnja 2020. Pristupljeno 21. studenoga 2020.

fda.gov

https://www.fda.gov/media/144245/download
Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions (engleski). Pristupljeno 22. prosinca 2020.
Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate. U.S. Food and Drug Administration (FDA) (priopćenje). Pristupljeno 20. studenoga 2020. Ovaj članak sadrži tekst iz ovog izvora, koji je u javnom vlasništvu.
Emergency Use Authorization for Vaccines Explained. U.S. Food and Drug Administration. 20. studenoga 2020. Pristupljeno 20. studenoga 2020. Ovaj članak sadrži tekst iz ovog izvora, koji je u javnom vlasništvu.

fiercebiotech.com

Nick Paul Taylor. 21. rujna 2016. Genentech lays $310M wager on BioNTech's mRNA cancer vaccine platform. FierceBiotech. Pristupljeno 7. prosinca 2020.

forbes.hu

Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához | Forbes.hu. forbes.hu (mađarski). 9. studenoga 2020. Inačica izvorne stranice arhivirana 26. siječnja 2021. Pristupljeno 22. prosinca 2020.

france24.com

BioNTech's founders: scientist couple in global spotlight. France 24 (engleski). 13. studenoga 2020. Pristupljeno 22. prosinca 2020.
BioNTech's founders: scientist couple in global spotlight. France24. 13. studenoga 2020. Pristupljeno 7. prosinca 2020.

genomeweb.com

TheraCode to Acquire JPT Peptide Technologies. GenomeWeb. 11. svibnja 2009. Pristupljeno 7. prosinca 2020.

globalnews.ca

Katie Dangerfield. 20. studenoga 2020. Pfizer files for emergency use of coronavirus vaccine in U.S. — what about in Canada?. Global News. Pristupljeno 25. studenoga 2020.

gov.hu

koronavirus.gov.hu

Az Európai Gyógyszerügynökség forgalmazásra ajánlja a Pfizer/BioNTech-vakcinát. koronavirus.gov.hu (mađarski). 21. prosinca 2020. Pristupljeno 22. prosinca 2020.

gov.uk

UK medicines regulator gives approval for first UK COVID-19 vaccine (engleski). Government of the United Kingdom. 2. prosinca 2020. Pristupljeno 2. prosinca 2020.

harvard.edu

ui.adsabs.harvard.edu

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen. 16. lipnja 2016. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature (engleski). str. 396–401. Bibcode:2016Natur.534..396K. doi:10.1038/nature18300. ISSN 1476-4687. PMID 27281205. Pristupljeno 11. studenoga 2020.

nasdaq.com

BioNTech SE (engleski). Nasdaq. Pristupljeno 12. studenoga 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen. 16. lipnja 2016. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature (engleski). str. 396–401. Bibcode:2016Natur.534..396K. doi:10.1038/nature18300. ISSN 1476-4687. PMID 27281205. Pristupljeno 11. studenoga 2020.

nytimes.com

Benjamin Mueller. 2. prosinca 2020. U.K. Approves Pfizer coronavirus vaccine, a first in the West. The New York Times. Pristupljeno 2. prosinca 2020.

politico.eu

Commission approves BioNTech/Pfizer vaccine. POLITICO (engleski). 21. prosinca 2020. Pristupljeno 22. prosinca 2020.
Belgian secretary of state accidentally reveals EU vaccine prices. POLITICO (engleski). 17. prosinca 2020. Pristupljeno 22. prosinca 2020.

publishing.service.gov.uk

assets.publishing.service.gov.uk

Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine (PDF) (engleski). Government of the United Kingdom. 2. prosinca 2020. Pristupljeno 2. prosinca 2020.

reuters.com

Spalding, Rebecca; Franklin, Joshua. 9. listopada 2019. Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility. Reuters. Pristupljeno 7. prosinca 2020.
Burger, Ludwig. 29. lipnja 2020. Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech. Reuters. Frankfurt. Pristupljeno 2. kolovoza 2020.
BioNTech in China alliance with Fosun over coronavirus vaccine candidate. Reuters. Frankfurt. 15. ožujka 2020. Pristupljeno 2. kolovoza 2020.
Burger, Ludwig. 22. travnja 2020. Germany approves trials of COVID-19 vaccine candidate. Reuters. Berlin. Pristupljeno 2. kolovoza 2020.
Shakil, Ismail; Mishra, Manas. 31. srpnja 2020. Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan. Reuters. Bengaluru. Pristupljeno 3. kolovoza 2020.
Erman, Michael; Banerjee, Ankur. 22. srpnja 2020. U.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine. Reuters. Pristupljeno 2. kolovoza 2020.
Smout, Alistair. 20. srpnja 2020. Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva. Reuters. London. Pristupljeno 2. kolovoza 2020.
Binnie, Anita Komuves, Benoit Van Overstraeten, Isla. 27. prosinca 2020. 'Window of hope': Europe begins to launch COVID-19 vaccinations. Reuters (engleski). Pristupljeno 27. prosinca 2020.

sec.report

BioNTech SE. 9. rujna 2019. Form F-1 (engleski). U.S. Securities and Exchange Commission. Inačica izvorne stranice arhivirana 14. veljače 2021. Pristupljeno 23. rujna 2020.

statnews.com

Helen Branswell. 20. studenoga 2020. Pfizer, BioNTech submit formal application to FDA to authorize Covid-19 vaccine. STAT. Pristupljeno 25. studenoga 2020.

swissmedic.ch

Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland (engleski). Pristupljeno 22. prosinca 2020.

web.archive.org

BioNTech SE. 9. rujna 2019. Form F-1 (engleski). U.S. Securities and Exchange Commission. Inačica izvorne stranice arhivirana 14. veljače 2021. Pristupljeno 23. rujna 2020.
SEC Filing | BioNTech. investors.biontech.de. Inačica izvorne stranice arhivirana 16. siječnja 2021. Pristupljeno 28. prosinca 2020.
Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához | Forbes.hu. forbes.hu (mađarski). 9. studenoga 2020. Inačica izvorne stranice arhivirana 26. siječnja 2021. Pristupljeno 22. prosinca 2020.
BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs. BioNTech. 4. rujna 2019. Inačica izvorne stranice arhivirana 29. lipnja 2023. Pristupljeno 27. prosinca 2020.

worldcat.org

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen. 16. lipnja 2016. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature (engleski). str. 396–401. Bibcode:2016Natur.534..396K. doi:10.1038/nature18300. ISSN 1476-4687. PMID 27281205. Pristupljeno 11. studenoga 2020.